471 related articles for article (PubMed ID: 29400072)
1. Role of Integrin Signaling Activation on the Development of Human T Cell Leukemia Virus-1 (HTLV-1)-Associated Myelopathy/Tropical Spastic Paraparesis: Its Relationship to HTLV-1-Infected CD4
Nakamura T; Satoh K; Nakamura H; Fukushima N; Nishiura Y; Furuya T; Ichinose K
AIDS Res Hum Retroviruses; 2018 Apr; 34(4):331-336. PubMed ID: 29400072
[TBL] [Abstract][Full Text] [Related]
2. HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP): the role of HTLV-I-infected Th1 cells in the pathogenesis, and therapeutic strategy.
Nakamura T
Folia Neuropathol; 2009; 47(2):182-94. PubMed ID: 19618340
[TBL] [Abstract][Full Text] [Related]
3. Immunopathogenesis of HTLV-I-associated myelopathy/tropical spastic paraparesis.
Nakamura T
Ann Med; 2000 Dec; 32(9):600-7. PubMed ID: 11209967
[TBL] [Abstract][Full Text] [Related]
4. HAM/TSP Pathogenesis: The Transmigration Activity of HTLV-1-Infected T Cells into Tissues.
Nakamura T
Pathogens; 2023 Mar; 12(3):. PubMed ID: 36986415
[TBL] [Abstract][Full Text] [Related]
5. Human T-lymphotropic virus type 1 (HTLV-1) and cellular immune response in HTLV-1-associated myelopathy/tropical spastic paraparesis.
Nozuma S; Kubota R; Jacobson S
J Neurovirol; 2020 Oct; 26(5):652-663. PubMed ID: 32705480
[TBL] [Abstract][Full Text] [Related]
6. Immunopathogenesis of HTLV-1-assoaciated myelopathy/tropical spastic paraparesis (HAM/TSP).
Fuzii HT; da Silva Dias GA; de Barros RJ; Falcão LF; Quaresma JA
Life Sci; 2014 May; 104(1-2):9-14. PubMed ID: 24704970
[TBL] [Abstract][Full Text] [Related]
7. HTLV-I production based on activation of integrin/ligand signaling in HTLV-I-infected T cell lines derived from HAM/TSP patients.
Fukushima N; Nakamura T; Nishiura Y; Ida H; Aramaki T; Eguchi K
Intervirology; 2008; 51(2):123-9. PubMed ID: 18552504
[TBL] [Abstract][Full Text] [Related]
8. Cytoplasmic Localization of HTLV-1 HBZ Protein: A Biomarker of HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP).
Baratella M; Forlani G; Raval GU; Tedeschi A; Gout O; Gessain A; Tosi G; Accolla RS
PLoS Negl Trop Dis; 2017 Jan; 11(1):e0005285. PubMed ID: 28095504
[TBL] [Abstract][Full Text] [Related]
9. Tropical spastic paraparesis and HTLV-1 associated myelopathy: clinical, epidemiological, virological and therapeutic aspects.
Gessain A; Mahieux R
Rev Neurol (Paris); 2012 Mar; 168(3):257-69. PubMed ID: 22405461
[TBL] [Abstract][Full Text] [Related]
10. Human T-Lymphotropic Virus Type 1-Induced Overexpression of Activated Leukocyte Cell Adhesion Molecule (ALCAM) Facilitates Trafficking of Infected Lymphocytes through the Blood-Brain Barrier.
Curis C; Percher F; Jeannin P; Montange T; Chevalier SA; Seilhean D; Cartier L; Couraud PO; Gout O; Gessain A; Ceccaldi PE; Afonso PV
J Virol; 2016 Aug; 90(16):7303-7312. PubMed ID: 27252538
[TBL] [Abstract][Full Text] [Related]
11. Presence of tropical spastic paraparesis/human T-cell lymphotropic virus type 1-associated myelopathy (TSP/HAM)-like among HIV-1-infected patients.
Casseb J; de Oliveira AC; Vergara MP; Montanheiro P; Bonasser F; Meilman Ferreira C; Smid J; Duarte AJ
J Med Virol; 2008 Mar; 80(3):392-8. PubMed ID: 18205234
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic strategies in HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP).
Nakamura T; Nishiura Y; Eguchi K
Cent Nerv Syst Agents Med Chem; 2009 Jun; 9(2):137-49. PubMed ID: 20021347
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of T Regulatory Lymphocytes Transcription Factors in HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP) Patients.
Ghezeldasht SA; Sadeghian H; Azarpazhooh MR; Shamsian SAA; Rafatpanah H; Mahmoodi M; Rezaee SA
Appl Biochem Biotechnol; 2017 Aug; 182(4):1403-1414. PubMed ID: 28101786
[TBL] [Abstract][Full Text] [Related]
14. Flow cytometry evaluation of the T-cell receptor Vbeta repertoire among human T-cell lymphotropic virus type-1 (HTLV-1) infected individuals: effect of interferon alpha therapy in HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP).
Saito M; Nose H; Usuku K; Sabouri AH; Matsuzaki T; Izumo S; Arimura K; Osame M
J Neurol Sci; 2006 Jul; 246(1-2):37-43. PubMed ID: 16545396
[TBL] [Abstract][Full Text] [Related]
15. HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) inflammatory network.
Goncalves DU; Proietti FA; Barbosa-Stancioli EF; Martins ML; Ribas JG; Martins-Filho OA; Teixeira-Carvalho A; Peruhype-Magalhães V; Carneiro-Proietti AB
Inflamm Allergy Drug Targets; 2008 Jun; 7(2):98-107. PubMed ID: 18691139
[TBL] [Abstract][Full Text] [Related]
16. Altered expression of degranulation-related genes in CD8+ T cells in human T lymphotropic virus type I infection.
Malta TM; Silva IT; Pinheiro DG; Santos AR; Pinto MT; Panepucci RA; Takayanagui OM; Tanaka Y; Covas DT; Kashima S
AIDS Res Hum Retroviruses; 2013 May; 29(5):826-36. PubMed ID: 23301858
[TBL] [Abstract][Full Text] [Related]
17. Increased HTLV type 1 tax specific CD8+ cells in HTLV type 1-asociated myelopathy/tropical spastic paraparesis: correlation with HTLV type 1 proviral load.
Kubota R; Nagai M; Kawanishi T; Osame M; Jacobson S
AIDS Res Hum Retroviruses; 2000 Nov; 16(16):1705-9. PubMed ID: 11080814
[TBL] [Abstract][Full Text] [Related]
18. T CD4+ cells count among patients co-infected with human immunodeficiency virus type 1 (HIV-1) and human T-cell leukemia virus type 1 (HTLV-1): high prevalence of tropical spastic paraparesis/HTLV-1-associated myelopathy (TSP/HAM).
Casseb J; Posada-Vergara MP; Montanheiro P; Fukumori LM; Olah I; Smid J; Duarte AJ; Penalva de Oliveira AC
Rev Inst Med Trop Sao Paulo; 2007; 49(4):231-3. PubMed ID: 17823752
[TBL] [Abstract][Full Text] [Related]
19. Expression of TSLC1 in patients with HAM/TSP.
Takenouchi N; Tanaka M; Sato T; Yao J; Fujisawa JI; Izumo S; Kubota R; Matsuura E
J Neurovirol; 2020 Jun; 26(3):404-414. PubMed ID: 32285300
[TBL] [Abstract][Full Text] [Related]
20. Human T cell lymphotropic virus type I (HTLV-I)-specific CD4+ T cells: immunodominance hierarchy and preferential infection with HTLV-I.
Goon PK; Igakura T; Hanon E; Mosley AJ; Barfield A; Barnard AL; Kaftantzi L; Tanaka Y; Taylor GP; Weber JN; Bangham CR
J Immunol; 2004 Feb; 172(3):1735-43. PubMed ID: 14734756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
